Skip to main content
. 2019 May 12;10(9):2057–2062. doi: 10.7150/jca.29383

Table 1.

Difference in LMR according to clinical characteristics in ESCC patients

Cases
Variables N %
Sex Male 582 85.6
Female 98 14.4
Age at therapy initiation (years) Median 61
Interquartile range (56-67)
Pathology grade Well differentiated 49 7.2
middle differentiated 449 66.0
Poorly differentiated 166 24.4
Undifferentiated 2 0.3
Missing 14 2.1
Depth of tumor T1a-1b 64 9.4
T2 131 19.3
T3 485 71.3
Lymph node metastasis N0 296 43.5
N1 213 31.3
N2 118 17.4
N3 53 7.8
Pathological stage 1a-1b 116 17.1
2a-2b 229 33.7
3a-3c 335 49.3
Vessel invasive Yes 210 30.9
No 470 69.1
Nerve infiltration Yes 254 37.4
No 426 62.6
Treatment regimen S 461 67.8
S plus postoperative C 155 22.8
S plus postoperative CRT 64 9.4
Hospital time after operation (days) Median 11
Interquartile range (10-14)
LMR Median 3.17
Interquartile range (2.33-4.33)

Abbreviations: S: surgery; C: chemotherapy; CRT: chemoradiotherapy; LMR: lymphocyte to monocyte ratio.